Spyre Therapeutics, Inc.SYRENASDAQ
Loading
Stockholders Equity Over TimeExpanding
Percentile Rank100
3Y CAGR+142.3%
5Y CAGR+38.6%
Year-over-Year Change
Net worth of the company (assets minus liabilities)
3Y CAGR
+142.3%/yr
vs -7.1%/yr prior
5Y CAGR
+38.6%/yr
Recent acceleration
Acceleration
+149.3pp
Accelerating
Percentile
P100
Near historical high
vs 5Y Ago
5.1x
Strong expansion
Streak
3 yr
Consecutive growthExpanding
| Period | Value | YoY Change |
|---|---|---|
| 2025 | $715.24M | +38.1% |
| 2024 | $517.80M | +181.4% |
| 2023 | $184.02M | +265.8% |
| 2022 | $50.30M | -40.1% |
| 2021 | $83.94M | -40.0% |
| 2020 | $139.83M | +132.7% |
| 2019 | $60.08M | -10.9% |
| 2018 | $67.43M | +34.0% |
| 2017 | $50.34M | -20.1% |
| 2016 | $62.97M | - |